Although these sarcomas have variable cell phenotypes, transcriptomes, prevalence, and prognoses, they are all driven by FUS, EWSR1, or TAF15 (sometimes referred to as the ‘FET’ gene family) fused to a transcription factor. This evidence concerns the gene TAF15 and sarcoma.